Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization

Patients hospitalized with coronavirus disease 2019 (COVID-19) often receive empiric antibiotic coverage. Procalcitonin (PCT) is a biomarker with Food and Drug Administration–approved guidance cutoffs for antibiotic use in lower respiratory tract infections. Herein we describe the implementation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Fratoni, Andrew J, Kois, Abigail K, Colmerauer, Jessica L, Linder, Kristin E, Nicolau, David P, Kuti, Joseph L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494375/
https://www.ncbi.nlm.nih.gov/pubmed/36176570
http://dx.doi.org/10.1093/ofid/ofac468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494375/
https://www.ncbi.nlm.nih.gov/pubmed/36176570
http://dx.doi.org/10.1093/ofid/ofac468

Ejemplares similares